Magnetic resonance imaging-targeted prostate biopsy changed everything (so everything has to change)

被引：1
|
作者：
Vickers, Andrew [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10017 USA
来源：
BJU INTERNATIONAL | 2024年 / 133卷 / 04期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1111/bju.16285
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：354 / 355
页数：2
相关论文
共 50 条
  • [41] Multiparametric magnetic resonance imaging-targeted biopsies in the detection of clinically significant prostate cancer
    Charalampos, Fragkoulis
    INDIAN JOURNAL OF UROLOGY, 2020, 36 (03) : 229 - 230
  • [42] Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy
    Gandaglia, Giorgio
    Ploussard, Guillaume
    Valerio, Massimo
    Marra, Giancarlo
    Moschini, Marco
    Martini, Alberto
    Roumiguie, Mathieu
    Fossati, Nicola
    Stabile, Armando
    Beauval, Jean-Baptiste
    Malavaud, Bernard
    Scuderi, Simone
    Barletta, Francesco
    Afferi, Luca
    Rakauskas, Arnas
    Gontero, Paolo
    Mattei, Agostino
    Montorsi, Francesco
    Briganti, Alberto
    EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (06): : 739 - 747
  • [43] Optimizing multiparametric magnetic resonance imaging-targeted biopsy and detection of clinically significant prostate cancer: the role of core number and location
    Robin Martin
    Yassir Belahsen
    Jean-Paul Noujeim
    Yolene Lefebvre
    Marc Lemort
    Maxime Deforche
    Nicolas Sirtaine
    Thierry Roumeguere
    Simone Albisinni
    Alexandre Peltier
    Romain Diamand
    World Journal of Urology, 2023, 41 : 1519 - 1525
  • [44] Magnetic Resonance Imaging-Targeted and Systematic Biopsy for Detection of Grade Progression in Patients on Active Surveillance for Prostate Cancer EDITORIAL COMMENT
    Morash, Chris
    JOURNAL OF UROLOGY, 2021, 205 (05): : 1358 - 1359
  • [45] Biochemically recurrent prostate cancer in the era of EMBARK and PSMA PET imaging: everything has changed, except the patients
    Einstein, David J.
    Aragon-Ching, Jeanny B.
    Karzai, Fatima
    Madan, Ravi A.
    CURRENT OPINION IN ONCOLOGY, 2024, 36 (03) : 164 - 168
  • [46] Reducing or Increasing Overtreatment? How Do We Measure the Impact of Magnetic Resonance Imaging-targeted Biopsy on Prostate Cancer Mortality?
    Taneja, Samir S.
    EUROPEAN UROLOGY, 2024, 86 (03) : 238 - 239
  • [47] Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial
    Hu, Jim C.
    Schaeffer, Edward M.
    Vickers, Andrew J.
    EUROPEAN UROLOGY, 2024, 86 (01) : e13 - e13
  • [48] Optimizing multiparametric magnetic resonance imaging-targeted biopsy and detection of clinically significant prostate cancer: the role of core number and location
    Martin, Robin
    Belahsen, Yassir
    Noujeim, Jean-Paul
    Lefebvre, Yolene
    Lemort, Marc
    Deforche, Maxime
    Sirtaine, Nicolas
    Roumeguere, Thierry
    Albisinni, Simone
    Peltier, Alexandre
    Diamand, Romain
    WORLD JOURNAL OF UROLOGY, 2023, 41 (06) : 1519 - 1525
  • [49] Potential Candidates for Focal Therapy in Prostate Cancer in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Large Multicenter Cohort Study
    von Hardenberg, Jost
    Borkowetz, Angelika
    Siegel, Fabian
    Kornienko, Kira
    Westhoff, Niklas
    Jordan, Tobias B.
    Hoffmann, Manuela
    Drerup, Martin
    Lieb, Verena
    Taymoorian, Kasra
    Schostak, Martin
    Ganzer, Roman
    Hoefner, Thomas
    Cash, Hannes
    Bruendl, Johannes
    EUROPEAN UROLOGY FOCUS, 2021, 7 (05): : 1002 - 1010
  • [50] Questions and answers on prostate multiparameter magnetic resonance imaging: Everything a urologist should know
    Catala, V.
    Salas, D.
    Esquena, S.
    Mateu, S.
    Algaba, F.
    Palou, J.
    de la Torre, P.
    ACTAS UROLOGICAS ESPANOLAS, 2016, 40 (06): : 339 - 352
12345